917 related articles for article (PubMed ID: 21426763)
21. Colposcopic evaluation of pre-invasive and early cervical carcinoma with histologic correlation.
Shahida SM; Mirza TT; Saleh AF; Islam MA
Mymensingh Med J; 2012 Apr; 21(2):200-6. PubMed ID: 22561759
[TBL] [Abstract][Full Text] [Related]
22. Difference Between Cryotherapy and Follow Up Low Grade Squamous Lesion of Cervix Uteri.
Jahic M; Jahic E; Mulavdic M; Hadzimehmedovic A
Med Arch; 2017 Aug; 71(4):280-283. PubMed ID: 28974850
[TBL] [Abstract][Full Text] [Related]
23. Conservative management of cervical intraepithelial neoplasia (CIN(2-3)) in pregnant women.
Vlahos G; Rodolakis A; Diakomanolis E; Stefanidis K; Haidopoulos D; Abela K; Georgountzos V; Michalas S
Gynecol Obstet Invest; 2002; 54(2):78-81. PubMed ID: 12566748
[TBL] [Abstract][Full Text] [Related]
24. Colposcopic management of abnormal cervical cytology in pregnancy.
LaPolla JP; O'Neill C; Wetrich D
J Reprod Med; 1988 Mar; 33(3):301-6. PubMed ID: 3361522
[TBL] [Abstract][Full Text] [Related]
25. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.
Wang J; Andrae B; Sundström K; Ström P; Ploner A; Elfström KM; Arnheim-Dahlström L; Dillner J; Sparén P
BMJ; 2016 Feb; 352():i276. PubMed ID: 26869597
[TBL] [Abstract][Full Text] [Related]
26. [Clinical analysis of cervical screening in 2329 pregnant women].
Wang Y; Yu Y; Xiao L; Mi X; Fu L; Luo Y
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Aug; 34(9):1355-8. PubMed ID: 25263375
[TBL] [Abstract][Full Text] [Related]
27. Clinical management of cervical intraepithelial neoplasia in pregnant and postpartum women.
Wu YM; Wang T; He Y; Song F; Wang Y; Zhu L; Kong WM; Duan W; Zhang WY
Arch Gynecol Obstet; 2014 May; 289(5):1071-7. PubMed ID: 24196304
[TBL] [Abstract][Full Text] [Related]
28. Cervicovaginal cytology in the detection of recurrence after cervical cancer treatment.
Rimel BJ; Ferda A; Erwin J; Dewdney SB; Seamon L; Gao F; DeSimone C; Cotney KK; Huh W; Massad LS
Obstet Gynecol; 2011 Sep; 118(3):548-553. PubMed ID: 21860282
[TBL] [Abstract][Full Text] [Related]
29. [Endocervical curretage: an analysis of results in 1997 women].
Li N; Zhang WH; Wu LY; Li AL; Qiao YL; Li L; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):406-8. PubMed ID: 15355644
[TBL] [Abstract][Full Text] [Related]
30. Evaluating cytology for the detection of invasive cervical cancer.
Landy R; Castanon A; Hamilton W; Lim AW; Dudding N; Hollingworth A; Sasieni PD
Cytopathology; 2016 Jun; 27(3):201-9. PubMed ID: 26126636
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of endocervical curettage for detecting dysplastic lesions in women with atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) Papanicolaou smears.
Poomtavorn Y; Suwannarurk K; Thaweekul Y; Maireang K
Asian Pac J Cancer Prev; 2014; 15(8):3461-4. PubMed ID: 24870740
[TBL] [Abstract][Full Text] [Related]
32. The application of human papilloma virus genotyping for the identification of neoplasm lesions in the cervix of women with abnormal cytology smears.
Ciszek B; Heimrath J; Ciszek M
Adv Clin Exp Med; 2012; 21(6):759-66. PubMed ID: 23457134
[TBL] [Abstract][Full Text] [Related]
33. The incidence of cervical intraepithelial neoplasia in a population of pregnant women with an abnormal cytology.
Pruski D; Malkowska-Walczak B; Paluszkiewicz A; Kędzia W
Ginekol Pol; 2017; 88(1):20-23. PubMed ID: 28157250
[TBL] [Abstract][Full Text] [Related]
34. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
35. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
36. Clinical management and follow-up of squamous intraepithelial cervical lesions during pregnancy and postpartum.
Frega A; Scirpa P; Corosu R; Verrico M; Scarciglia ML; Primieri MR; Palazzo A; Iacovelli R; Moscarini M
Anticancer Res; 2007; 27(4C):2743-6. PubMed ID: 17695441
[TBL] [Abstract][Full Text] [Related]
37. Significance of AGUS Pap smears in pregnant and postpartum women.
Chhieng DC; Elgert P; Cangiarella JF; Cohen JM
Acta Cytol; 2001; 45(3):294-9. PubMed ID: 11393057
[TBL] [Abstract][Full Text] [Related]
38. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
39. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
40. [Triage value of high risk human papilloma virus detection in women with abnormal cervical cytology].
Jin Y; Pan LY; Wang YF; Cheng XM; Lang JH
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1173-6. PubMed ID: 18844110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
